2
N.N.M. Ishak et al. / Journal of Molecular Structure 1198 (2019) 126888
issue resulting in significant morbidity and mortality. Thus, there is
a need to develop new types of drugs that can overcome this
growing problem. Transition metal complexes as metallo-drugs are
believed to have great potential as anti-microbial agents [1,2]. Small
molecules like transition metal complexes have been proven to
have strong binding interactions with DNA via both covalent and
non-covalent interaction modes. The interaction modes play a
significant role in the biological activities of metal complexes
especially as antibacterial, antifungal and anticancer agents [3]. For
example, the Cu(II) Schiff base complex derived from 4-
chloroanthranilic and salicylaldehyde showed an intercalative
and benzimidazole with tridentate thiosemicarbazide Schiff bases
and Ni(II) acetate. Since scarce information has been reported on
mixed ligand metal complexes containing imidazole derivatives as
a co-ligand and in view of the previous studies on the biological
relevance of related mixed-ligand metal complexes, we report
herein the synthesis, characterisation, cytotoxicity, antibacterial
activity and DNA-binding studies of mixed ligand metal complexes
derived from tridentate ONS Schiff bases with imidazole
derivatives.
binding mode with CT-DNA with
a high Kb constant of
2. Experimental
1.93 ꢀ 104 L molꢁ1, indicative of strong binding, as compared to
other
similar
complexes
such
as
[Cu(naph-leu)phen]
2.1. Instrumentation and materials
CH3OH$0.5H2O (Kb, 4.87 ꢀ 103 L molꢁ1) and [Cu(sal-
L-val)phen] (Kb,
6.48 ꢀ 103 L molꢁ1) [4]. This has formed the basis of most research
in the synthesis of metal complexes via various methods and
different designs to develop new metal-based drugs.
All chemicals were of analytical grade (A.R. from Alfa Aesar,
Aldrich or Merck) and used without further purification. Elemental
analysis (C, H, N) were performed using a LECO CHNS-932
elemental analyser. Infrared (IR) spectra were recorded on Perki-
nElmer 100 spectrophotometer (4000-280 cmꢁ1). Molar conduc-
tance of 10ꢁ3 M solutions of the mixed-ligand Ni(II) complexes in
DMSO were measured using a Jenway 4310 conductivity meter
Transition metal complexes of thiosemicarbazone ligands have
received considerable interest due to its ability to disrupt DNA
synthesis by causing modification in the reductive conversion of
ribonucleotides to deoxyribonucleotides [5]. Furthermore, by
introducing aldehydes or ketones to thiosemicarbazones, the Schiff
bases that are formed can interact with metal ions to form com-
plexes that have stable four, five or six coordination [6,7]. The
biological activity of thiosemicarbazones is facilitated by their
chelating ability with transition metal ions. Coordination to metal
centre through sulphur and nitrogen donors would form bidentate,
tridentate or even multidentate ligands, thus giving rise to com-
plexes of different geometries and properties that would alter or
enhancing their biological properties [8e12]. Studies also reported
that the biological activity of the metal complexes of
thiosemicarbazone-derived Schiff bases often had higher, and se-
lective bioactivities as compared to the corresponding free thio-
semicarbazones [13e15]. The biological activity of these metal
complexes containing Schiff bases have also been reported to have
enhanced activities when ligated to a co-ligand, forming mixed-
ligand complexes. For instance, the Cu(II) complexes of a tri-
with
a dip-type cell electrode. Magnetic susceptibility was
measured with a Sherwood Scientific MSB-AUTO magnetic sus-
ceptibility balance at 298 K. UVeVis spectra were recorded by using
a Shimadzu UV-2501 PC recording spectrophotometer in the range
of 1000e200 nm. Metal content of the complexes were determined
using Inductive Coupled Plasma-Optical Emission Spectrometry.
Nuclear Magnetic Resonance (1H NMR and 13C NMR) spectra were
recorded using an JNM ECA400 NMR spectrometer.
2.2. Synthesis of 4-methyl-3-thiosemicarbazide-2,4-
dihydroxybenzaldehyde (MT24D) and 4-phenyl-3-
thiosemicarbazide-2,4-dihydroxybenzaldehyde (PT24D)
20 mmol (2.76 g) of 2,4-dihydroxybenzaldehyde was dissolved
in 30 ml ethanol and added to an equimolar solution of 4-methyl-3-
dentate
Schiff
base,
salicylaldehyde-4-methyl-3-
thiosemicarbazone in the presence of imidazole or benzimidazole
exhibited enhanced activity against MCF-7 and MDA-MD-231
breast cancer cell lines [16] as compared to the mono-ligand
metal complex.
thiosemicarbazide
(20 mmol,
2.10 g)
or
4-phenyl-3-
thiosemicarbazide (20 mmol, 3.34 g) in the same solvent. The
mixture was stirred and reduced to half volume from initial vol-
ume. The precipitate that formed was recrystallised with cold
ethanol. The yields were dried over silica gel overnight.
Imidazole derivatives are an important class of heterocycles,
being the core fragment of different natural products and biological
systems. The imidazole ring is biologically relevant as it can mimic
the histidine moiety. It is able to act as a co-ligand in metal com-
plexes, potentially enabling them to bind with biomolecules [17].
They occupy a unique place in the field of medicinal chemistry
owing to their potent biological activity especially as antiprotozoal,
antifungal, and antihypertensive agents [18e21]. Bearing donors
and acceptors capable of hydrogen bonding, imidazole- and
benzimidazole-containing metal complexes often possess inter-
esting supramolecular architectures [22]. In the study of imidazole
derivatives, Brandenburg reported that the compound synthesized
from Cu(II) with salicylideneanthranilic acid and a co-ligand 2-
methylimidazole [Cu(SAA)(MeImH)] had distinct superoxide dis-
mutase activity (SOD) which resulted in 50% inhibition
For MT24D. Yield: (86%). Colour: light yellow, melting point:
215e216 ꢂC. Anal. Calc. Data are given in Table 2, IR, ATR v(cmꢁ1):
3240 v(OeH), 3336 v(NeH), 1616 v(C¼N), 1013 v(NeN), 866 v(C¼S).
1H NMR (400 MHz, DMSO‑d6,
d ppm): 11.41 (s, 1H, NH), 9.45 (q, 1H,
J ¼ 32 Hz, NH), 8.37 (s,1H, CH), 8.35 (s, 2H, OH phenolic), 7.33 (d,1H,
J ¼ 4 Hz, Ar H), 6.74 (d, 1H, J ¼ 8 Hz, Ar H), 6.62 (t, 1H, J ¼ 24 Hz, Ar
H), 2.45 (d, 3H, J ¼ 12 Hz, CH3). 13C NMR (100 MHz, DMSO‑d6,
d
ppm): 177.12 (C8), 146.11 (C5), 144.67 (C3), 140.56 (C7), 121.45
(C6), 118.87 (C4), 116.98 (C1), 116.85 (C2), 31.38 (C9). MS m/z 225
(Mþ1).
For PT24D. Yield: (89%). Colour: yellow, melting point:
205e206 ꢂC. Anal. Calc, Data are given in Table 2, IR, ATR v(cmꢁ1):
3160 v(OeH), 3240 v(NeH),1592 v(C¼N),1022 v(NeN), 825 v(C¼S).
1H NMR (400 MHz, DMSO‑d6,
d ppm): 11.71 (s, 1H, NH), 9.96 (s, 1H,
(IC50 ¼ 35
m
mol dmꢁ3) higher than that of the native enzyme
m
OH phenolic), 9.55 (s, 1H, OH phenolic), 8.94 (q, 1H, J ¼ 32 Hz, NH),
8.43 (s, 1H, CH), 7.51 (d, 2H, J ¼ 8 Hz, Ar H), 7.49 (d, 1H, J ¼ 12 Hz, Ar
H), 7.33 (t, 2H, J ¼ 16 Hz, Ar H), 7.14 (t, 1H, J ¼ 16 Hz, Ar H), 6.78 (d,
1H, J ¼ 16 Hz, Ar H), 6.64 (t, 1H, J ¼ 12 Hz, Ar H). 13C NMR (100 MHz,
(IC50 ¼ 0.004
mol dmꢁ3) [23]. This higher IC50 value was hypoth-
esized to be due to the strong ligand field created by the tridentate
Schiff base that would interfere with the interaction of the com-
plexed copper ion with the superoxide radicals [24].
DMSO‑d6, d ppm): 176.23 (C8), 146.13 (C5), 145.39 (C3), 141.76 (C7),
In the present study, a new series of mixed-ligand metal com-
plexes was formed by reacting single atom donor ligands, imidazole
139.68 (C9), 128 (C10, C14), 126.23 (C10, C11), 125.57 (C1), 121.54
(C6), 119.40 (C4), 118.59 (C2), 117.20 (C12). MS m/z 287 (Mþ1).